Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Aust N Z J Obstet Gynaecol ; 63(6): 821-824, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37317572

RESUMEN

Perinatal mental health (PMH) disorders affect about one in seven women in the peripartum period with significant maternal and neonatal effects. It is important to understand trends in PMH to plan for necessary resource allocation. This study reviews the PMH trends in a major tertiary obstetric centre over 10 years from 2013 to 2022. Over this period there was a significant increase in the rates of anxiety from 7.4 to 18.4% (P < 0.001), depression from 13.6 to 16.3% (P < 0.001) and anxiety and/or depression from 16.5 to 22.6% (P < 0.001). These findings provide further information for resource allocation to improve long-term outcomes.


Asunto(s)
Trastornos Mentales , Salud Mental , Embarazo , Recién Nacido , Femenino , Humanos , Trastornos Mentales/epidemiología , Ansiedad/epidemiología , Ansiedad/psicología , Depresión/epidemiología , Depresión/psicología
2.
Australas Psychiatry ; 29(3): 278-281, 2021 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-33070625

RESUMEN

OBJECTIVE: To discuss challenges with the diagnosis of autoimmune psychosis (AP) in people with chronic psychotic disorders. METHOD: We present a case of a 23-year-old man with an exacerbation of treatment-refractory psychosis after receiving intravenous immunoglobulin (IVIG) for suspected AP, diagnosed 4 years after the onset of psychosis. We highlight the diagnostic and management challenges in such cases. RESULTS: The diagnosis of AP in people with long-standing illness relies on the interpretation of non-specific clinical and laboratory findings in individuals with psychosocial problems and challenges of acceptance and adherence to complex medical investigations and treatments. Equivocal results from investigations undertaken without logical clinical reasoning can lead to inappropriate interventions that are costly and can cause iatrogenic harm. CONCLUSION: Psychiatrists should restrict screening for antineuronal antibodies in people with chronic psychosis to those with higher risk features such as persistent treatment refractory symptoms with concurrent neurological signs and symptoms. Further research informing the clinical circumstances for antineuronal antibody testing is needed.


Asunto(s)
Autoanticuerpos/sangre , Inmunoglobulinas Intravenosas/efectos adversos , Psicosis Inducidas por Sustancias/tratamiento farmacológico , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/terapia , Autoanticuerpos/líquido cefalorraquídeo , Encefalitis , Humanos , Inmunoglobulinas Intravenosas/administración & dosificación , Masculino , Trastornos Psicóticos/diagnóstico , Receptores de N-Metil-D-Aspartato , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA